gastric cancer–stimulated pathways in cancer-associated fibroblasts and implications for treatment
Published 9 months ago • 47 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
0:25
dr. opyrchal: if a patient’s tumor is er /pr , how does that impact your treatment decisions?
-
1:40
anxa6 sumoylation helps suppress epithelial cancer progression by altering egfr signaling
-
1:27
the value of an intermediate recurrence score® result in the oncotype dx® breast cancer assay
-
0:55
breast cancer recurrence test | oncostem
-
4:24
risk of early versus late recurrence
-
1:00
dr. parker on the results of the radicals-rt trial in prostate cancer
-
0:31
cancer interception unlocked - episode 1
-
2:27
figure360: trends in cancer, jia et al., figure 2
-
1:24
phase i study of cd123 nk cell engager sar443579 in r/r aml, b-all or hr-mds
-
1:54
protein cmtm7 promotes autophagy, tumor suppression in cancer cells
-
1:35
why is the recurrence score helpful to breast cancer patients?
-
4:18
managing patients with high risk of recurrence who are unlikely to benefit from eet
-
1:54
regulation of efferocytosis as a novel cancer therapy
-
2:26
what is a cancer recurrence? why might a cancer recurrence happen?
-
2:13
n9831 trial: genes associated with early and late recurrence in her2 breast cancer
-
2:14
cancer: transcriptional regulator of emt (4/11)
-
0:31
augusta oncology | vanessa d.
-
6:08
bad in cancer signaling
-
7:11
genomic testing for risk of late recurrence/asco guidelines